{"id":1558,"date":"2014-01-15T18:40:23","date_gmt":"2014-01-15T17:40:23","guid":{"rendered":"http:\/\/slanedeti.sk\/cms\/?p=1558"},"modified":"2014-01-15T18:41:38","modified_gmt":"2014-01-15T17:41:38","slug":"kvalita-zivota-u-pacientov-s-cystickou-fibrozou","status":"publish","type":"post","link":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558","title":{"rendered":"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou – 3. \u010das\u0165"},"content":{"rendered":"

Cie\u013eom v\u00fdskumu bolo zisti\u0165, nako\u013eko CF ovplyv\u0148uje celkov\u00fa poci\u0165ovan\u00fa kvalitu \u017eivota pacientov s CF a tie\u017e to, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa ochoren\u00edm najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 naopak CF nato\u013eko neovplyv\u0148uje. Zis\u0165ovali sme tie\u017e, \u010di existuj\u00fa rozdiely v celkovej kvalite \u017eivota a v jednotliv\u00fdch dimenzi\u00e1ch kvality \u017eivota medzi skupinami pacientov l\u00ed\u0161iacimi sa vekom, pohlav\u00edm a z\u00e1va\u017enos\u0165ou zdravotn\u00e9ho stavu. Na z\u00e1klade teoretick\u00e9ho pozadia sme si zvolili nasledovn\u00e9 hypot\u00e9zy a v\u00fdskumn\u00fa ot\u00e1zku:<\/p>\n

H1: Predpokladali sme, \u017ee pacienti s CF so zl\u00fdm zdravotn\u00fdm stavom bud\u00fa vykazova\u0165 ni\u017e\u0161ie sk\u00f3re celkovej kvality \u017eivota v porovnan\u00ed s pacientmi s CF s dobr\u00fdm zdravotn\u00fdm stavom a s priemern\u00fdm zdravotn\u00fdm stavom.<\/p><\/blockquote>\n

Ke\u010f\u017ee CF ovplyv\u0148uje celkov\u00e9 fungovanie pacienta v jeho ka\u017edodennom \u017eivote a hor\u0161\u00ed zdravotn\u00fd stav predpoklad\u00e1 zhor\u0161en\u00e9 fungovanie, nazd\u00e1vame sa, \u017ee r\u00f4zny zdravotn\u00fd stav podmie\u0148uje aj rozdiely v pre\u017e\u00edvanej kvalite \u017eivota. Preto by pacienti s hor\u0161\u00edm zdravotn\u00fdm stavom mali poci\u0165ova\u0165 zn\u00ed\u017een\u00fa kvalitu \u017eivota v porovnan\u00ed s pacientmi s lep\u0161\u00edm zdravotn\u00fdm stavom. Prv\u00fd v\u00fdskum kvality \u017eivota u pacientov s CF, ktor\u00fd uskuto\u010dnil Orenstein et al. (1989), taktie\u017e zis\u0165oval kvalitu \u017eivota v spojen\u00ed s p\u013e\u00facnymi funkciami. Autori si vybrali hodnoty FEV1, PEFR a FEF25-75%, ktor\u00e9 s\u00fa ochoren\u00edm v\u00fdznamne zasiahnut\u00e9, pri\u010dom najsilnej\u0161\u00ed vz\u0165ah s kvalitou \u017eivota mala hodnota FEV1 (jednosekundov\u00e1 vit\u00e1lna kapacita). Progresia ochorenia sa naj\u010dastej\u0161ie podob\u00e1 poklesu hodnoty FEV1. T\u00e1to hodnota sa preto n\u00e1sledne objavila v mno\u017estve \u010fal\u0161\u00edch v\u00fdskumov kvality \u017eivota u pacientov s CF. Pr\u00e1ve hodnotu FEV1 sme si ako ukazovate\u013e z\u00e1va\u017enosti zdravotn\u00e9ho stavu zvolili aj my.<\/p>\n

H2: Predpokladali sme, \u017ee skupina pacientov s CF s dobr\u00fdm zdravotn\u00fdm stavom bude vykazova\u0165 vy\u0161\u0161ie sk\u00f3re v dimenzii ‚fyzick\u00e9 fungovanie‘ a v dimenzii ‚respira\u010dn\u00e9 sympt\u00f3my‘ ako skupina pacientov s CF s priemern\u00fdm a so zl\u00fdm zdravotn\u00fdm stavom.<\/p><\/blockquote>\n

Schmidt et al. (2009) porovn\u00e1vali skupinu det\u00ed s CF s dobr\u00fdm a hor\u0161\u00edm zdravotn\u00fdm stavom. Pacienti boli zaraden\u00ed do t\u00fdchto skup\u00edn pod\u013ea hodnoty FEV1. Skupina s dobr\u00fdm stavom vykazovala v\u00fdznamne vy\u0161\u0161ie sk\u00f3re v dimenzii ‚fyzick\u00e9 fungovanie‘, ‚respira\u010dn\u00e9 sympt\u00f3my‘ a ‚obraz tela‘ ako skupina s hor\u0161\u00edm zdravotn\u00fdm stavom.<\/p>\n

H3: Predpokladali sme, \u017ee \u017eeny s CF bud\u00fa vykazova\u0165 ni\u017e\u0161ie sk\u00f3re celkovej kvality \u017eivota v porovnan\u00ed s mu\u017emi s CF.<\/p><\/blockquote>\n

Niektor\u00ed autori tvrdia, \u017ee \u017eeny a mu\u017ei s CF maj\u00fa odli\u0161n\u00e9 vn\u00edmanie kvality \u017eivota. Boli zisten\u00e9 v\u00fdznamn\u00e9 rozdiely medzi mu\u017emi a \u017eenami v kvalite \u017eivota. \u017deny dosiahli ni\u017e\u0161ie sk\u00f3re na v\u0161etk\u00fdch dimenzi\u00e1ch kvality \u017eivota s v\u00fdnimkou rolov\u00e9ho fungovania. Genderov\u00e9 rozdiely sa nepreuk\u00e1zali iba pri fyzickom fungovan\u00ed, \u010do m\u00f4\u017ee znamena\u0165, \u017ee pri fyzickom fungovan\u00ed s\u00fa vek a z\u00e1va\u017enos\u0165 ochorenia d\u00f4le\u017eitej\u0161\u00edmi faktormi ako pohlavie. V inom v\u00fdskume porovn\u00e1vaj\u00facom skupinu diev\u010dat a chlapcov s CF boli preuk\u00e1zan\u00e9 signifikantn\u00e9 rozdiely v dimenzii ‚emocion\u00e1lny stav‘, ‚z\u00e1\u0165a\u017e lie\u010dby‘ a ‚za\u017e\u00edvacie sympt\u00f3my‘, pri\u010dom vo v\u0161etk\u00fdch vykazovali ni\u017e\u0161ie sk\u00f3re diev\u010dat\u00e1.<\/p>\n

H4: Predpokladali sme, \u017ee star\u0161\u00ed pacienti s CF bud\u00fa vykazova\u0165 ni\u017e\u0161ie sk\u00f3re celkovej kvality \u017eivota v porovnan\u00ed s mlad\u0161\u00edmi pacientmi s t\u00fdmto ochoren\u00edm.<\/p><\/blockquote>\n

Cystick\u00e1 fibr\u00f3za je progres\u00edvne ochorenie, zdravotn\u00fd stav pacientov sa teda \u010dasom zhor\u0161uje, \u010do predpoklad\u00e1 aj zni\u017eovanie kvality \u017eivota. Viacero v\u00fdskumov nazna\u010duje, \u017ee existuje rozdiel v poci\u0165ovanej kvalite \u017eivota u star\u0161\u00edch a mlad\u0161\u00edch pacientov s CF. Hegarty et al. (2008) zistili v\u00fdznamne vy\u0161\u0161ie sk\u00f3re v dimenzi\u00e1ch ‚emocion\u00e1lny stav‘, ‚obraz tela‘ a ‚z\u00e1\u0165a\u017e lie\u010dby‘ u mlad\u0161\u00edch pacientov. Vo v\u00fdskume Schmidta et al. (2009) mlad\u0161\u00ed pacienti vykazovali celkovo lep\u0161\u00ed zdravotn\u00fd stav, \u010do nazna\u010duje aj vy\u0161\u0161iu kvalitu \u017eivota.<\/p>\n

V1: Zis\u0165ovali sme, \u010di bud\u00fa star\u0161\u00ed pacienti s CF vykazova\u0165 ni\u017e\u0161ie sk\u00f3re v dimenzi\u00e1ch ‚fyzick\u00e9 fungovanie‘, ‚respira\u010dn\u00e9 sympt\u00f3my‘ a ‚vitalita‘ v porovnan\u00ed s mlad\u0161\u00edmi pacientmi.<\/p><\/blockquote>\n

Niektor\u00e9 v\u00fdskumy ud\u00e1vaj\u00fa, \u017ee existuje signifikantn\u00fd vz\u0165ah medzi vekom a dosiahnutou kvalitou \u017eivota, pri\u010dom deti s CF dosiahli vy\u0161\u0161ie sk\u00f3re takmer vo v\u0161etk\u00fdch dimenzi\u00e1ch. Ako sme uviedli, CF je progres\u00edvne ochorenie, pri\u010dom t\u00e1to progresia sa prejavuje najm\u00e4 v zhor\u0161uj\u00facich sa p\u013e\u00facnych funkci\u00e1ch. Preto predpoklad\u00e1me, \u017ee star\u0161\u00ed pacienti bud\u00fa vykazova\u0165 ni\u017e\u0161iu kvalitu \u017eivota pr\u00e1ve v dimenzi\u00e1ch, ktor\u00e9 sa priamo t\u00fdkaj\u00fa fyzick\u00e9ho stavu z\u00e1visl\u00e9ho na p\u013e\u00facnych funkci\u00e1ch.<\/p>\n

V\u00fdskumn\u00fd s\u00fabor<\/h4>\n

Podmienkou \u00fa\u010dasti vo v\u00fdskume bola diagn\u00f3za CF a vek nad 18 rokov. Roku 2010 bolo na Slovensku potvrden\u00fdch 333 pr\u00edpadov CF, z toho 63% dospel\u00fdch pacientov. N\u00e1\u0161ho v\u00fdskumu sa z\u00fa\u010dastnilo spolu 76 dospel\u00fdch pacientov s CF. Z celkov\u00e9ho po\u010dtu bolo 49 \u017eien (64,5%) a 27 mu\u017eov (35,5%). Respondenti boli vo veku od 18 do 47 rokov, pri\u010dom priemern\u00fd vek bol 25,58 rokov. Priemern\u00fd vek \u017eien bol 26 a mu\u017eov 24,81 rokov. V demografickej \u010dasti dotazn\u00edka sme zis\u0165ovali rodinn\u00fd stav, vzdelanie a pracovn\u00fa situ\u00e1ciu respondentov. Z celkov\u00e9ho po\u010dtu bolo 49 respondentov slobodn\u00fdch (64,6%), 12 \u017eij\u00facich s partnerom (15,8%), 11 \u017eij\u00facich v man\u017eelstve (14,5%) a 4 respondenti boli rozveden\u00ed (5,3%). \u010co sa t\u00fdka najvy\u0161\u0161ieho ukon\u010den\u00e9ho vzdelania respondentov, v\u00e4\u010d\u0161ina dosiahla \u00fapln\u00e9 stredo\u0161kolsk\u00e9 s maturitou (44,7%), \u010falej 19 respondentov uviedlo ne\u00fapln\u00e9 stredo\u0161kolsk\u00e9 (25%), 10 respondentov stredn\u00fa odborn\u00fa \u0161kolu (13,2%), 9 \u00fapln\u00e9 vysoko\u0161kolsk\u00e9 vzdelanie (11,8%) a 4 ne\u00fapln\u00e9 vysoko\u0161kolsk\u00e9 vzdelanie (5,3%). V \u010dase v\u00fdskumu bolo 22 respondentov zamestnan\u00fdch na pln\u00fd alebo \u010diasto\u010dn\u00fd \u00fav\u00e4zok (28,9%), 20 chodilo do \u0161koly (26,3%), 9 si h\u013eadalo pr\u00e1cu (11,8%), 8 nepracovalo (10,5%) a 2 mali individu\u00e1lny \u0161tudijn\u00fd pl\u00e1n doma (2,6%). A\u017e 15 respondentov (19,7%) uviedlo, \u017ee nenav\u0161tevuj\u00fa \u0161kolu ani nepracuj\u00fa, preto\u017ee im to znemo\u017e\u0148uje zdravotn\u00fd stav. Na ot\u00e1zku, \u010di boli po\u010das posledn\u00e9ho polroka mimo \u0161koly \u010di zamestnania z d\u00f4vodov s\u00favisiacich s ich ochoren\u00edm, odpovedalo 41 respondentov nie (53,9%) a 35 respondentov \u00e1no (46,1%).<\/p>\n

\"die\u0165a<\/p>\n

 <\/p>\n

Pl\u00e1n v\u00fdskumu<\/h4>\n

Kvantitat\u00edvny v\u00fdskum, ktor\u00fd sme realizovali, prebiehal v mesiacoch febru\u00e1r a marec roku 2013. Oslovili sme Mudr. Branislava Remi\u0161a z CF centra pre dospel\u00fdch pacientov v Ru\u017einove a Mudr Hanu Kayserov\u00fa z detsk\u00e9ho CF centra v Podunajsk\u00fdch Biskupiciach. Obozn\u00e1mili sme ich s cie\u013emi n\u00e1\u0161ho v\u00fdskumu a po\u017eiadali o spolupr\u00e1cu, s ktorou s\u00fahlasili. Pre zozbieranie v\u00e4\u010d\u0161ieho mno\u017estva \u00fadajov sme dotazn\u00edky pacientom zasielali tie\u017e v on-line podobe.<\/p>\n

Met\u00f3dou zberu \u00fadajov bol Revidovan\u00fd dotazn\u00edk pre cystick\u00fa fibr\u00f3zu. Je jedn\u00fdm z m\u00e1la \u0161pecifick\u00fdch n\u00e1strojov, ktor\u00e9 s\u00fa ur\u010den\u00e9 na meranie kvality \u017eivota konkr\u00e9tne u pacientov s CF a jedin\u00fdm n\u00e1strojom pre \u0161pecifick\u00e9 ochorenie, ktor\u00fd umo\u017e\u0148uje sledovanie pacienta po\u010das cel\u00e9ho \u017eivota. Obsahuje 50 polo\u017eiek rozdelen\u00fdch do 12 dimenzi\u00ed, zah\u0155\u0148aj\u00facich v\u0161eobecn\u00e9 aspekty kvality \u017eivota (vitalita, vn\u00edmanie zdravia, fyzick\u00e9 fungovanie, emocion\u00e1lne fungovanie, soci\u00e1lne fungovanie, rolov\u00e9 fungovanie) a \u0161pecifick\u00e9 aspekty (poruchy jedenia, respira\u010dn\u00e9 sympt\u00f3my, za\u017e\u00edvacie sympt\u00f3my, obraz tela, z\u00e1\u0165a\u017e zo strany lie\u010dby a hmotnos\u0165). Vy\u0161\u0161ie sk\u00f3re zna\u010d\u00ed vy\u0161\u0161iu kvalitu \u017eivota.<\/p>\n

Na spracovanie a anal\u00fdzu z\u00edskan\u00fdch v\u00fdskumn\u00fdch \u00fadajov sme pou\u017eili relevantn\u00e9 \u0161tatistick\u00e9 testy, ktor\u00e9 boli aplikovan\u00e9 prostredn\u00edctvom \u0161pecializovan\u00e9ho \u0161tatistick\u00e9ho po\u010d\u00edta\u010dov\u00e9ho programu Statistical Package for the Social Sciences (SPSS).<\/p>\n

V\u00fdsledky<\/h4>\n

Na z\u00e1klade zozbieran\u00fdch \u00fadajov sme vypo\u010d\u00edtali priemern\u00e9 hodnoty, \u0161tandardn\u00fa odch\u00fdlku, minim\u00e1lne a maxim\u00e1lne hodnoty hrub\u00e9ho sk\u00f3re jednotliv\u00fdch dimenzi\u00ed kvality \u017eivota a tie\u017e celkov\u00e9ho hrub\u00e9ho sk\u00f3re kvality \u017eivota dosiahnut\u00e9ho v dotazn\u00edku (tab. 1).<\/p>\n

V\u00fdskumn\u00fd s\u00fabor sme rozdelili na tri skupiny pod\u013ea z\u00e1va\u017enosti zdravotn\u00e9ho stavu, reprezentovan\u00e9ho hodnotou FEV1. Vyl\u00fa\u010den\u00fdch z v\u00fdskumn\u00e9ho s\u00faboru muselo by\u0165 10 respondentov, ktor\u00ed neuviedli hodnotu FEV1. Skupinu s dobr\u00fdm zdravotn\u00fdm stavom (S1) tvorili pacienti s hodnotou FEV1 v\u00e4\u010d\u0161ou alebo rovnou ako 80%, skupinu s priemern\u00fdm zdravotn\u00fdm stavom (S2) tvorili pacienti s FEV1 v intervale od 36% do 79% a skupinu so zl\u00fdm zdravotn\u00fdm stavom (S3) pacienti s FEV1 ni\u017e\u0161ou alebo rovnou ako 35%.
\nV\u00fdsledky preuk\u00e1zali, \u017ee skupina pacientov s CF so zl\u00fdm zdravotn\u00fdm stavom (S3) poci\u0165ovala signifikantne ni\u017e\u0161iu kvalitu \u017eivota ako skupina s priemern\u00fdm (S2) a s dobr\u00fdm zdravotn\u00fdm stavom (S1). Hypot\u00e9za H1 sa potvrdila. Z v\u00fdsledkov vypl\u00fdva, \u017ee skupina pacientov s dobr\u00fdm zdravotn\u00fdm stavom (S1) vykazovala signifikantne vy\u0161\u0161ie sk\u00f3re v dimenzii ‚respira\u010dn\u00e9 sympt\u00f3my‘ a v dimenzii ‚fyzick\u00e9 fungovanie‘ ako skupina s priemern\u00fdm (S2) a so zl\u00fdm zdravotn\u00fdm stavom (S3). Hypot\u00e9za H2 sa n\u00e1m taktie\u017e potvrdila. Predpoklad, \u017ee \u017eeny vykazuj\u00fa signifikantne ni\u017e\u0161ie sk\u00f3re celkovej kvality \u017eivota sa n\u00e1m v\u0161ak nepotvrdil. \u017deny s CF nepoci\u0165ovali v\u00fdznamne zn\u00ed\u017een\u00fa celkov\u00fa kvalitu \u017eivota v porovnan\u00ed s mu\u017emi s t\u00fdmto ochoren\u00edm. Hypot\u00e9za H3 sa teda nepotvrdila. Napriek tomu, \u017ee sme v celkovej kvalite \u017eivota medzi skupinou mu\u017eov a \u017eien nezistili signifikantn\u00fd rozdiel, sk\u00famali sme rozdiely v jednotliv\u00fdch dimenzi\u00e1ch kvality \u017eivota. Celkovo sme zistili ni\u017e\u0161ie sk\u00f3re u \u017eien vo v\u0161etk\u00fdch dimenzi\u00e1ch kvality \u017eivota okrem dimenzie ‚hmotnos\u0165‘ a ‚obraz tela‘.<\/p>\n

Pod\u013ea veku sme v\u00fdskumn\u00fd s\u00fabor rozdelili na dve skupiny. Skupinu V1 tvorili participanti do 26 rokov (18-25) a skupinu V2 participanti star\u0161\u00ed ako 26 rokov (26-47 rokov). Z v\u00fdsledkov vypl\u00fdva, \u017ee star\u0161\u00ed pacienti s CF nedosahuj\u00fa v porovnan\u00ed s mlad\u0161\u00edmi pacienti s CF v\u00fdznamne ni\u017e\u0161ie celkov\u00e9 sk\u00f3re kvality \u017eivota. Hypot\u00e9za H4 sa n\u00e1m nepotvrdila. V\u00fdsledky preuk\u00e1zali, \u017ee v dimenzii ‚respira\u010dn\u00e9 sympt\u00f3my‘ neexistuje signifikantn\u00fd rozdiel v dosiahnutom sk\u00f3re medzi skupinou mlad\u0161\u00edch (V1) a star\u0161\u00edch pacientov (V2). Signifikantn\u00fd rozdiel sme v\u0161ak zistili v ostatn\u00fdch dvoch dimenzi\u00e1ch ‚fyzick\u00e9 fungovanie‘ a ‚vitalita‘, pri\u010dom v oboch dosiahli vy\u0161\u0161ie sk\u00f3re mlad\u0161\u00ed participanti (V1).<\/p>\n

Tab.1: Deskript\u00edvna anal\u00fdza celkovej kvality \u017eivota a jednotliv\u00fdch dimenzi\u00ed<\/em><\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
<\/td>\nRozsah<\/strong><\/td>\nMin<\/strong><\/td>\nMax<\/strong><\/td>\nPriemer<\/strong><\/td>\nSD<\/strong><\/td>\n<\/tr>\n
Celkov\u00e9 sk\u00f3re<\/td>\n93<\/td>\n87<\/td>\n180<\/td>\n139,11<\/td>\n21,89<\/td>\n<\/tr>\n
Emocion\u00e1lne fungovanie<\/td>\n13<\/td>\n7<\/td>\n20<\/td>\n14,28<\/td>\n3,13<\/td>\n<\/tr>\n
Obraz tela<\/td>\n9<\/td>\n3<\/td>\n12<\/td>\n8,91<\/td>\n2,66<\/td>\n<\/tr>\n
Soci\u00e1lne fungovanie<\/td>\n14<\/td>\n10<\/td>\n24<\/td>\n18,07<\/td>\n3,18<\/td>\n<\/tr>\n
Vitalita<\/td>\n8<\/td>\n6<\/td>\n14<\/td>\n10,55<\/td>\n1,89<\/td>\n<\/tr>\n
Rolov\u00e9 fungovanie<\/td>\n11<\/td>\n5<\/td>\n16<\/td>\n11,70<\/td>\n2,37<\/td>\n<\/tr>\n
Fyzick\u00e9 fungovanie<\/td>\n24<\/td>\n8<\/td>\n32<\/td>\n22,49<\/td>\n6,73<\/td>\n<\/tr>\n
Poruchy jedenia<\/td>\n7<\/td>\n5<\/td>\n12<\/td>\n10,55<\/td>\n1,99<\/td>\n<\/tr>\n
Z\u00e1\u0165a\u017e zo strany lie\u010dby<\/td>\n8<\/td>\n4<\/td>\n12<\/td>\n7,88<\/td>\n1,71<\/td>\n<\/tr>\n
Vn\u00edmanie zdravia<\/td>\n9<\/td>\n3<\/td>\n12<\/td>\n7,74<\/td>\n2,42<\/td>\n<\/tr>\n
Hmotnos\u0165<\/td>\n3<\/td>\n1<\/td>\n4<\/td>\n2,28<\/td>\n1,16<\/td>\n<\/tr>\n
Respira\u010dn\u00e9 sympt\u00f3my<\/td>\n13<\/td>\n8<\/td>\n21<\/td>\n13,47<\/td>\n3,05<\/td>\n<\/tr>\n
Za\u017e\u00edvacie sympt\u00f3my<\/td>\n7<\/td>\n5<\/td>\n12<\/td>\n9,17<\/td>\n1,64<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

V\u00fdskumn\u00fd s\u00fabor bol pre potreby testovania hypot\u00e9z a v\u00fdskumnej ot\u00e1zky rozdelen\u00fd na z\u00e1klade veku, pohlavia \u010di z\u00e1va\u017enosti zdravotn\u00e9ho stavu. V pr\u00edlohe uv\u00e1dzame priemern\u00e9 hodnoty hrub\u00e9ho sk\u00f3re jednotliv\u00fdch dimenzi\u00ed kvality \u017eivota u jednotliv\u00fdch skup\u00edn v\u00fdskumn\u00e9ho s\u00faboru (pr\u00edloha 1,2,3). Priemern\u00e9 sk\u00f3re celkovej kvality \u017eivota v skupine mu\u017eov, \u017eien, star\u0161\u00edch (V2) a mlad\u0161\u00edch (V1) pacientov a pacientov v dobrom (S1), priemernom (S2) a zlom (S3) zdravotnom stave uv\u00e1dzame v nasledovnej tabu\u013eke (tab.2).<\/p>\n

Tab. 2: Deskript\u00edvna anal\u00fdza – hrub\u00e9 sk\u00f3re celkovej kvality \u017eivota<\/em><\/p>\n

\n\n\n\n\n
<\/td>\nMu\u017ei<\/strong><\/td>\n\u017deny<\/strong><\/td>\nV1<\/strong><\/td>\nV<\/strong><\/td>\nS1<\/strong><\/td>\nS<\/strong><\/td>\nS3<\/strong><\/td>\n<\/tr>\n
Kvalita \u017eivota<\/td>\n142,85<\/td>\n138,17<\/td>\n142,00<\/td>\n136,3<\/td>\n153,91<\/td>\n138,16<\/td>\n113,8<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Cieľom výskumu bolo zistiť, nakoľko CF ovplyvňuje celkovú pociťovanú kvalitu života pacientov s CF a tiež to, ktoré dimenzie kvality života sú ochorením najviac znížené a ktoré naopak CF natoľko neovplyvňuje. Zisťovali sme tiež, či existujú rozdiely v celkovej kvalite … Continued<\/a><\/p>\n","protected":false},"author":10,"featured_media":1559,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"kt_blocks_editor_width":"","footnotes":""},"categories":[253],"tags":[],"class_list":["post-1558","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-o-cystickej-fibroze"],"yoast_head":"\nKvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti<\/title>\n<meta name=\"description\" content=\"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti\" \/>\n<meta property=\"og:description\" content=\"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558\" \/>\n<meta property=\"og:site_name\" content=\"Slan\u00e9 deti\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/slanedeti\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-15T17:40:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-01-15T17:41:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Martina Ondreji\u010dkov\u00e1\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Martina Ondreji\u010dkov\u00e1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558\"},\"author\":{\"name\":\"Martina Ondreji\u010dkov\u00e1\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\"},\"headline\":\"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou – 3. \u010das\u0165\",\"datePublished\":\"2014-01-15T17:40:23+00:00\",\"dateModified\":\"2014-01-15T17:41:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558\"},\"wordCount\":1908,\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/dieta_v_posteli.png\",\"articleSection\":[\"O cystickej fibr\u00f3ze\"],\"inLanguage\":\"sk-SK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558\",\"name\":\"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/dieta_v_posteli.png\",\"datePublished\":\"2014-01-15T17:40:23+00:00\",\"dateModified\":\"2014-01-15T17:41:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\"},\"description\":\"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.\",\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\\\/1558#primaryimage\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/dieta_v_posteli.png\",\"contentUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/dieta_v_posteli.png\",\"width\":400,\"height\":400,\"caption\":\"die\u0165a v posteli\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/\",\"name\":\"Slan\u00e9 deti\",\"description\":\"Inform\u00e1cie o cystickej fibr\u00f3ze\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/533fb80bc91e78157014b20fef001594\",\"name\":\"Martina Ondreji\u010dkov\u00e1\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/author\\\/martina\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti","description":"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558","og_locale":"sk_SK","og_type":"article","og_title":"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti","og_description":"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.","og_url":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558","og_site_name":"Slan\u00e9 deti","article_publisher":"http:\/\/www.facebook.com\/slanedeti","article_published_time":"2014-01-15T17:40:23+00:00","article_modified_time":"2014-01-15T17:41:38+00:00","og_image":[{"width":400,"height":400,"url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png","type":"image\/png"}],"author":"Martina Ondreji\u010dkov\u00e1","twitter_misc":{"Autor":"Martina Ondreji\u010dkov\u00e1","Predpokladan\u00fd \u010das \u010d\u00edtania":"9 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558#article","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558"},"author":{"name":"Martina Ondreji\u010dkov\u00e1","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594"},"headline":"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou – 3. \u010das\u0165","datePublished":"2014-01-15T17:40:23+00:00","dateModified":"2014-01-15T17:41:38+00:00","mainEntityOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558"},"wordCount":1908,"image":{"@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png","articleSection":["O cystickej fibr\u00f3ze"],"inLanguage":"sk-SK"},{"@type":"WebPage","@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558","url":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558","name":"Kvalita \u017eivota u pacientov s cystickou fibr\u00f3zou - 3. \u010das\u0165 - Slan\u00e9 deti","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/#website"},"primaryImageOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558#primaryimage"},"image":{"@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png","datePublished":"2014-01-15T17:40:23+00:00","dateModified":"2014-01-15T17:41:38+00:00","author":{"@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594"},"description":"Cie\u013eom v\u00fdskumu bolo zisti\u0165, ako CF ovplyv\u0148uje poci\u0165ovan\u00fa kvalitu \u017eivota pacientov, ktor\u00e9 dimenzie kvality \u017eivota s\u00fa najviac zn\u00ed\u017een\u00e9 a ktor\u00e9 neovplyv\u0148uje.","inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/slanedeti.sk\/cms\/kvalita-zivota-u-pacientov-s-cystickou-fibrozou\/1558#primaryimage","url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png","contentUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2014\/01\/dieta_v_posteli.png","width":400,"height":400,"caption":"die\u0165a v posteli"},{"@type":"WebSite","@id":"https:\/\/slanedeti.sk\/cms\/#website","url":"https:\/\/slanedeti.sk\/cms\/","name":"Slan\u00e9 deti","description":"Inform\u00e1cie o cystickej fibr\u00f3ze","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/slanedeti.sk\/cms\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/533fb80bc91e78157014b20fef001594","name":"Martina Ondreji\u010dkov\u00e1","url":"https:\/\/slanedeti.sk\/cms\/author\/martina"}]}},"_links":{"self":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/1558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/comments?post=1558"}],"version-history":[{"count":0,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/1558\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media\/1559"}],"wp:attachment":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media?parent=1558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/categories?post=1558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/tags?post=1558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}